Abstract
Introduction:
Coronary artery disease (CAD) is the end result of the accumulation of atheromatous plaques within the walls of the coronary arteries that supply the myocardium. 1 CAD is the largest single cause of death in the UK and many parts of the world. Each year there are approximately 60 deaths per 100,000. Sudden cardiac death is a prominent feature of CAD. One in every six coronary attacks was found to present with sudden death as the first, last, and only symptom. 2 In USA, among adults age 20 and older, the total number of coronary heart disease (CHD) in 2006 was 16,800,000 (about 8,700,000 men and 8,100,000 women). CHD caused about one of every five deaths in the United States in 2005. It is the largest single killer of American males and females. 3 National data on incidence and mortality of coronary heart disease are few in Bangladesh. The prevalence of coronary heart disease was estimated as 3.3/1000 in 1976 and 17.2/1000 in 1986 indicating 5 folds in the disease in 10 years. 4, 5 
HIGH SENSITIVE C-REACTIVE PROTEIN (hs-CRP) AND ITS CORRELATION WITH ANGIOGRAPHIC SEVERITY OF PATIENT WITH CORONARY ARTERY DISEASE (CAD)
Traditionally there are some conventional risk factors like age, male sex, positive family history, hypertension, smoking, hyperlipidaemia, metabolic syndrome, diabetes, lack of exercise, obesity, and some emerging risk factors, like C-Reactive Protein, Homocysteine, Fibrinogen. 6 Less than 50% of the CAD can be ascribed to traditional risk factors and rests are unexplained. 7 CRP has emerged as the most exquisitely sensitive systemic marker of inflammation and a powerful predictive marker of future cardiovascular risk. Role for inflammation has become well established over the past decade or more in theories describing the atherosclerotic disease process. 8 A body of evidence now suggests that atherosclerosis represents a chronic inflammatory response to vascular injury caused by a variety of agents that activate or injure endothelium and promote lipoprotein infiltration, retention, and modification, combined with inflammatory cell entry, retention and activation. 9 So, from a pathological viewpoint, all stages, i.e., initiation, growth, and complication of the atherosclerotic plaque might be considered to be an inflammatory response to injury. 10,11 Creactive protein (CRP) is one of the acute phase proteins that increase during systemic inflammation. 12 Several prospective studies recently showed that plasma high sensitive Creactive protein (hs-CRP) levels, a more sensitive CRP test, are a powerful predictor of future myocardial infarction and cardiac death among apparently healthy individuals. 13 However, the association between the plasma hs-CRP levels and the severity of coronary stenosis in subjects remains controversial. Some studies previously demonstrated such associations whereas other could not found it. 14, 15 This study was performed to determine whether the concentrations of hs-CRP correlate with the coronary atherosclerotic disease assessed by coronary angiography.
Objectives:
General Objective: 1. To correlate the levels of hs-CRP with angiographic severity of coronary artery stenosis in patients with IHD admitted for CAG in DMCH. 
Correlation between hs CRP with vessel score (n=90).
Hs CRP was expressed in mg/L and vessel score ranges from 0 to 3 depending on the number of vessel involve. Significant positive correlations were found between hs-CRP and vessel score.
The values of Pearson's correlation coefficient was 0.7409 which is highly significant (p<0.001). Therefore, there was linear positive correlation between hs-CRP and vessel score (Fig. 1) . 
Correlation between hs CRP with stenosis score (n=90).
Hs CRP was expressed in mg/L and stenosis score ranges from 0 to 112. Significant positive correlations were found between hs-CRP and stenosis score.
The values of Pearson's correlation coefficient was 0.6648 which is highly significant (p<0.001). Therefore, there was linear positive correlation between hs-CRP and stenosis score (Fig. 2) .
(p<0.001). Therefore, there was linear positive correlation between hs-CRP and extent score (Fig.-3) .
Discussion
This cross sectional study was carried out with an aim to correlate the levels of hs-CRP with angiographic severity of coronary artery stenosis in patients with IHD admitted for CAG in DMCH and to correlate the levels of hs-CRP with vessel score, stenosis score and extent score.
A total of 90 patients with IHD age ranging from 20 to 70 years were included in the study, who were admitted for CAG in the department of Cardiology, Dhaka Medical College during July 2008 to December 2009.
The patients were divided into three groups according to their level of hs-CRP, which were <1.0 mg/L was considered as group I, hs-CRP range from 1.0 to 3.0 mg/L considered as group II and >3.0 mg/L considered as group III. According to hs-CRP level 22(24.4%) cases were in group I, 33(36.7%) cases group II and rest 35(38.9%) cases group III.
Danesh et al. 15 reported that in general, CRP concentrations increase among smokers with increased cigarette consumption. 16 Regarding the smoking status it was found in this current study that 40.9%, 66.7% and 60.0% was smoker in group I, group II and group III respectively. Koenig et al. 16 have shown in their series 50.0 percent of the patients were hypertensive which is a little inferior to the present study, where the current study observed that hypertensive was 59.1% in group I, 57.6% in group II and 65.7% in group III. Hypertensive patients was comparatively higher in group III but no significant (p>0.05) difference was found among three group.
In the present study, diabetes mellitus was higher in group II and group III with compared to group I, but no significant (p>0.05) difference was found among three groups. Diabetes mellitus observed in the present study are in higher with Koenig et al.
The family history of IHD and dyslipidemia were almost parallel among three groups, which were not statistically significant (p>0.05) 
Correlation between hs CRP with extent score (n=90).
Hs CRP was expressed in mg/L and extent score ranges from 0 to 80. Significant positive correlations were found between hs-CRP and extent score.
The values of Pearson's correlation coefficient was 0.6386 which is highly significant difference among three groups. Nearly one third of the patient had family history of IHD and two third had dyslipidemia of the study patients in the current study.
In this current series it was observed that the mean (±SD) vessel score was 0.3±0. In this present study a significant (p<0.001) positive correlation coefficient (r=0.7409) was found between hs-CRP and vessel score, which indicates that there was linear positive correlation between hs-CRP and vessel score. Similarly, significant (p<0.001) positive correlation coefficient (r=0.6648 and r=0.6386) were found between hs-CRP with stenosis score and hs-CRP and extent score. Nyandak et al. 17 who have observed in their studies, Spearman's correlation coefficient between hs-CRP and angiographic stenosis score was r = 0.316 (p<0.004) and hs-CRP with angiographic extent score was r= 0.338 (p<0.005). 18 Higher hs-CRP levels were associated with higher stenosis and extent score in CAD patients, which are consistent with the present study results.
So, hs-CRP is a single cardiovascular risk factor and increases CRP concentration within reference limit are associated with future cardiovascular events. Elevated level of CRP can predict the coronary atherosclerotic disease burden.
Conclusion:
Significant positive correlation was observed between the extent of coronary artery disease and hs-CRP levels. Similarly hs-CRP levels were found to be higher in patients with higher degree of angiographic stenosis. This shows that hs-CRP levels have a positive correlation with the disease burden in CAD patients. hs-CRP is a single cardiovascular risk factor and are associated with severity of disease. Increases CRP concentration within reference limit are associated with future cardiovascular events. Elevated level of CRP can predict the coronary atherosclerotic disease burden.
